利湿芍药方治疗湿热内蕴证溃疡性结肠炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R574.1

基金项目:


Clinical Study on Lishi Shaoyao Prescription for Ulcerative Colitis with Internal Accumulation of Damp-Heat Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察利湿芍药方治疗湿热内蕴证溃疡性结肠炎的临床疗效。方法:将64 例湿热内蕴证溃疡 性结肠炎患者采用随机数字表法分为2 组各32 例。对照组给予美沙拉嗪肠溶片口服治疗;治疗组给予利湿芍 药方中药口服治疗。用药4 周后,评价2 组腹泻、黏液便、脓血便、里急后重、腹痛及肛门灼热等临床症 状评分,血清炎症因子白细胞介素-6(IL-6)、白细胞介素-17(IL-17)、白细胞介素-4(IL-4) 及肿瘤坏死因 子-α(TNF-α) 的变化情况及Baron 内镜评分、Geboes 黏膜组织学评分的改善情况。结果:临床疗效总有效 率治疗组93.75%,对照组68.75%,2 组临床疗效比较,差异有统计学意义(P<0.05)。治疗后,2 组临床症状 各项评分均较治疗前降低,且治疗组临床症状各项评分均低于对照组(P<0.05)。治疗后,2 组炎症因子 IL-6、IL-17、TNF-α,以及Baron 内镜评分、Geboes 评分均降低,IL-4 水平升高,差异均有统计学意 义(P<0.05)。治疗后,治疗组IL-6、IL-17、TNF-α 水平,以及Baron 内镜评分、Geboes 评分均低于对照 组,IL-4 水平高于对照组,差异均有统计学意义(P<0.05)。结论:利湿芍药方治疗湿热内蕴证溃疡性结肠炎 可有效降低IL-6、IL-17 及TNF-α 的水平,升高IL-4 的水平,缓解炎症进展,缓解肠黏膜溃疡,从而改善腹 泻、黏液便、脓血便、里急后重、腹痛及肛门灼热等临床症状。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Lishi Shaoyao Prescription for ulcerative colitis with internal accumulation of damp- heat syndrome. Methods: A total of 64 cases of patients with ulcerative colitis with internal accumulation of damp-heat syndrome were divided into two groups according to the random number table method,with 32 cases in each group. The control group was treated with the oral administration of Mesalazin Enteric-Coated Tablets,and the treatment group was treated with the oral administration of Lishi Shaoyao Prescription. After 4-week administration,the scores of clinical symptoms including diarrhea, stool with mucus, stool with pus and blood, tenesmus, abdominal pain, and heat scorching the anus, the changes in the serum inflammatory factors including interleukin- 6 (IL- 6), interleukin-17 (IL-17),interleukin-4 (IL-4),and tumor necrosis factor-α (TNF-α),and the improvement of the Baron Scores for endoscopic grading and the Geboes Scores for mucosal histologic assessment were evaluated in the two groups. Results:The total clinical effective rate was 93.75% in the treatment group and 68.75% in the control group,the difference being significant (P<0.05). After treatment,each score of clinical symptoms in the two groups was decreased when compared with that before treatment,and the scores in the treatment group were lower than those in the control group (P<0.05). After treatment,the levels of IL- 6,IL- 17,and TNF- α,the Baron Scores,and the Geboes Scores in the two groups were decreased when compared with those before treatment, and the levels of IL- 4 were increased, differences being significant (P<0.05). After treatment,the levels of IL-6,IL-17,and TNF-α,the Baron Scores,and the Geboes Scores in the treatment group were lower than those in the control group,and the IL- 4 level was higher than that in the control group, differences being significant (P<0.05). Conclusion: Lishi Shaoyao Prescription for ulcerative colitis with internal accumulation of damp- heat syndrome can effectively reduce the levels of IL- 6,IL-17,and TNF-α,increase IL-4 level,relieve inflammation and intestinal mucosal ulcer, and improve the clinical symptoms including diarrhea,stool with mucus,stool with pus and blood,tenesmus,abdominal pain,and heat scorching the anus.

    参考文献
    相似文献
    引证文献
引用本文

李月华.利湿芍药方治疗湿热内蕴证溃疡性结肠炎临床研究[J].新中医,2023,55(8):58-63

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-04-25
  • 出版日期:
文章二维码